Background: COVID-19 severity and mortality are higher in patients with lung cancer due to
pulmonary complications. Understanding the mechanisms of SARS-COV-2 effect on lung …

The molecular mechanism of the pathological impact of COVID-19 in lung cancer patients
remains poorly understood to date. In this study, we used differential gene expression …

Genomic techniques such as next-generation sequencing and microarrays have facilitated
the identification and classification of molecular signatures inherent in cells upon viral …

Background Early research indicates that cancer patients are more vulnerable to adverse
outcomes and mortality when infected with severe acute respiratory syndrome coronavirus 2 …

Lung cancer patients with COVID-19 present an increased risk of developing severe
disease and, consequently, have poor outcomes. Determining SARS-CoV-2-host …

SARS-CoV-2 infections are rising at an alarming rate and various aspects of this pandemic
must be quickly and adequately addressed in order to enhance effective healthcare delivery …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
coronavirus variant that started the global pandemic and infected more than 12 million …

Abstract Background Coronavirus disease 2019 (COVID-19) greatly affects cancer patients,
especially those with lung cancer. This study aimed to identify potential drug targets for lung …

Introduction: Since the emergence of SARS-CoV-2 viruses, multiple mutant strains have
been identified. Infection with SARS-CoV-2 virus leads to alterations in host cell …

We identified 14 immune‐related differentially Expressed Genes (DEGs) between COVID‐
19 patients and normal controls and the receiver operator characteristic curve results …